Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001628280-18-012395
Filing Date
2018-10-09
Accepted
2018-10-09 16:05:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A kevinpollack-amendmentno1t.htm SC 13D/A 41845
2 EXHIBIT 1 kevinpollack-letteragreeme.htm EX-1 17713
  Complete submission text file 0001628280-18-012395.txt   61025
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Subject) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90404 | Film No.: 181113705
SIC: 1000 Metal Mining

Mailing Address 150 RAINVILLE ROAD TARPON SPRINGS FL 34689
Business Address
Pollack Kevin (Filed by) CIK: 0001553236 (see all company filings)

Type: SC 13D/A